Cargando…
Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning
The human immune system depends on the activity of cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and NKT cells in order to fight off a viral infection. Understanding the molecular mechanisms during this process and the role of individual proteins was greatly improved by the study of fami...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997030/ https://www.ncbi.nlm.nih.gov/pubmed/24795715 http://dx.doi.org/10.3389/fimmu.2014.00167 |
_version_ | 1782313136369434624 |
---|---|
author | Sieni, Elena Cetica, Valentina Hackmann, Yvonne Coniglio, Maria Luisa Da Ros, Martina Ciambotti, Benedetta Pende, Daniela Griffiths, Gillian Aricò, Maurizio |
author_facet | Sieni, Elena Cetica, Valentina Hackmann, Yvonne Coniglio, Maria Luisa Da Ros, Martina Ciambotti, Benedetta Pende, Daniela Griffiths, Gillian Aricò, Maurizio |
author_sort | Sieni, Elena |
collection | PubMed |
description | The human immune system depends on the activity of cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and NKT cells in order to fight off a viral infection. Understanding the molecular mechanisms during this process and the role of individual proteins was greatly improved by the study of familial hemophagocytic lymphohistiocytosis (FHL). Since 1999, genetic sequencing is the gold standard to classify patients into different subgroups of FHL. The diagnosis, once based on a clinical constellation of abnormalities, is now strongly supported by the results of a functional flow-cytometry screening, which directs the genetic study. A few additional congenital immune deficiencies can also cause a resembling or even identical clinical picture to FHL. As in many other rare human disorders, the collection and analysis of a relatively large number of cases in registries is crucial to draw a complete picture of the disease. The conduction of prospective therapeutic trials allows investigators to increase the awareness of the disease and to speed up the diagnostic process, but also provides important functional and genetic confirmations. Children with confirmed diagnosis may undergo hematopoietic stem cell transplantation, which is the only cure known to date. Moreover, detailed characterization of these rare patients helped to understand the function of individual proteins within the exocytic machinery of CTL, NK, and NKT cells. Moreover, identification of these genotypes also provides valuable information on variant phenotypes, other than FHL, associated with biallelic and monoallelic mutations in the FHL-related genes. In this review, we describe how detailed characterization of patients with genetic hemophagocytic lymphohistiocytosis has resulted in improvement in knowledge regarding contribution of individual proteins to the functional machinery of cytotoxic T- and NK-cells. The review also details how identification of these genotypes has provided valuable information on variant phenotypes. |
format | Online Article Text |
id | pubmed-3997030 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-39970302014-05-02 Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning Sieni, Elena Cetica, Valentina Hackmann, Yvonne Coniglio, Maria Luisa Da Ros, Martina Ciambotti, Benedetta Pende, Daniela Griffiths, Gillian Aricò, Maurizio Front Immunol Immunology The human immune system depends on the activity of cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and NKT cells in order to fight off a viral infection. Understanding the molecular mechanisms during this process and the role of individual proteins was greatly improved by the study of familial hemophagocytic lymphohistiocytosis (FHL). Since 1999, genetic sequencing is the gold standard to classify patients into different subgroups of FHL. The diagnosis, once based on a clinical constellation of abnormalities, is now strongly supported by the results of a functional flow-cytometry screening, which directs the genetic study. A few additional congenital immune deficiencies can also cause a resembling or even identical clinical picture to FHL. As in many other rare human disorders, the collection and analysis of a relatively large number of cases in registries is crucial to draw a complete picture of the disease. The conduction of prospective therapeutic trials allows investigators to increase the awareness of the disease and to speed up the diagnostic process, but also provides important functional and genetic confirmations. Children with confirmed diagnosis may undergo hematopoietic stem cell transplantation, which is the only cure known to date. Moreover, detailed characterization of these rare patients helped to understand the function of individual proteins within the exocytic machinery of CTL, NK, and NKT cells. Moreover, identification of these genotypes also provides valuable information on variant phenotypes, other than FHL, associated with biallelic and monoallelic mutations in the FHL-related genes. In this review, we describe how detailed characterization of patients with genetic hemophagocytic lymphohistiocytosis has resulted in improvement in knowledge regarding contribution of individual proteins to the functional machinery of cytotoxic T- and NK-cells. The review also details how identification of these genotypes has provided valuable information on variant phenotypes. Frontiers Media S.A. 2014-04-16 /pmc/articles/PMC3997030/ /pubmed/24795715 http://dx.doi.org/10.3389/fimmu.2014.00167 Text en Copyright © 2014 Sieni, Cetica, Hackmann, Coniglio, Da Ros, Ciambotti, Pende, Griffiths and Aricò. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Sieni, Elena Cetica, Valentina Hackmann, Yvonne Coniglio, Maria Luisa Da Ros, Martina Ciambotti, Benedetta Pende, Daniela Griffiths, Gillian Aricò, Maurizio Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning |
title | Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning |
title_full | Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning |
title_fullStr | Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning |
title_full_unstemmed | Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning |
title_short | Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning |
title_sort | familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997030/ https://www.ncbi.nlm.nih.gov/pubmed/24795715 http://dx.doi.org/10.3389/fimmu.2014.00167 |
work_keys_str_mv | AT sienielena familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning AT ceticavalentina familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning AT hackmannyvonne familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning AT conigliomarialuisa familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning AT darosmartina familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning AT ciambottibenedetta familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning AT pendedaniela familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning AT griffithsgillian familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning AT aricomaurizio familialhemophagocyticlymphohistiocytosiswhenrarediseasesshedlightonimmunesystemfunctioning |